Skip to main content
Equibles

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1086619 London, X0
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,745,950
+$1,993,869 QoQ
Shares Held
172,086
-3.9% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 311 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. RARE ranks #35 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 1,410,943 $99,683,122
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 169,270 $84,081,485
3 EXEL
Exelixis, Inc.
 669,005 $36,400,560
4 INSM
INSMED Inc
 298,372 $31,812,422
5 ALNY
Alnylam Pharmaceuticals, Inc.
 95,194 $28,656,248
6 MDGL
Madrigal Pharmaceuticals, Inc.
 51,630 $27,722,728
7 VERA
Vera Therapeutics, Inc.
 510,787 $21,917,869
8 TVTX
Travere Therapeutics, Inc.
 379,611 $21,565,700

All Filings in RARE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,745,950 172,086
2026-03-31 $3,752,081 179,097
2025-12-31 $4,039,605 175,635
2025-09-30 $4,529,175 150,571
2025-06-30 $12,223,250 336,173
2025-03-31 $9,569,759 264,285
2024-12-31 $15,825,093 376,161
2024-09-30 $10,158,150 182,865
2024-06-30 $14,690,701 357,438
2024-03-31 $11,909,591 255,078
2023-12-31 $11,957,486 250,052